Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Outcome Predictors of SD-OCT-Driven Intravitreal Ranibizumab in Choroidal Neovascularization due to Myopia ; volume:243 ; number:2 ; year:2020 ; pages:154-162
Ophthalmologica ; 243, Heft 2 (2020), 154-162
- Creator
-
Guichard, Maria-Magdalena
Peters, Géraldine
Tuerksever, Cengiz
Pruente, Christian
Hatz, Katja
- DOI
-
10.1159/000501040
- URN
-
urn:nbn:de:101:1-2020031123134734739271
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guichard, Maria-Magdalena
- Peters, Géraldine
- Tuerksever, Cengiz
- Pruente, Christian
- Hatz, Katja
Other Objects (12)
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China : Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization
Long-Term Outcomes following Intravitreal Ranibizumab for Choroidal Neovascularization Related to Nd:YAG Laser Macular Injury: A Case Report
The Role of Optical Coherence Tomography Angiography in Ranibizumab-Treated Choroidal Neovascularization in Choroidal Osteoma
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan
Characteristics of choroidal neovascularization in elderly eyes with high myopia not meeting the pathologic myopia definition
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China : Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization
Long-Term Outcomes following Intravitreal Ranibizumab for Choroidal Neovascularization Related to Nd:YAG Laser Macular Injury: A Case Report
The Role of Optical Coherence Tomography Angiography in Ranibizumab-Treated Choroidal Neovascularization in Choroidal Osteoma
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan
Characteristics of choroidal neovascularization in elderly eyes with high myopia not meeting the pathologic myopia definition
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China : Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization
Long-Term Outcomes following Intravitreal Ranibizumab for Choroidal Neovascularization Related to Nd:YAG Laser Macular Injury: A Case Report
The Role of Optical Coherence Tomography Angiography in Ranibizumab-Treated Choroidal Neovascularization in Choroidal Osteoma
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan